Dr. Priya Mahindra Nayyar, MD

Dr. Nayyar practices at Premier Dermatology in Sarasota, Florida.

Dr. Nayyar's NPI, 1649407719, was assigned on June 16, 2009. Dr. Nayyar graduated from SUNY Downstate Health Sciences University in 2009. Dr. Nayyar holds Florida license ME127446.

Dr. Nayyar's primary practice is Premier Dermatology, at 3328 Bee Ridge Rd, Sarasota, FL 34239 in Sarasota County. The practice phone is (941) 926-2300.

Dr. Nayyar's primary practice is Premier Dermatology in Sarasota, Florida. The medical group on file is Premier Dermatology LLC. Dmand AI also links Dr. Nayyar to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nayyar practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Nayyar's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Nayyar is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Nayyar's licenses on file in 2 states: Florida and New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and itchy rashes among the conditions Dr. Nayyar treats.

CMS data shows 10,254 Medicare services from Dr. Nayyar across 39 procedure codes in 2024, for 1,072 Medicare patients. Medicare paid $3,515,431 for them. Every service was in an office.

CMS counts 1,072 Medicare patients who saw Dr. Nayyar in 2024. The largest group is 65 to 74, with 446 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nayyar's median patient age at 68, with 57% women.

In 2024, Dr. Nayyar wrote 274 Medicare Part D claims for 161 patients. 97% of them were for generic drugs. CMS names the drug for 183 of them, across 5 drugs with 11 or more claims each, at $1,437 in total drug cost. In 2023, CMS named 212 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Nayyar for performance year 2024, reported individually. Dr. Nayyar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 226 procedures of melanoma (skin cancer) excision by Dr. Nayyar, more than 98% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Nayyar. The most frequent topics are Skin Neoplasms. Dr. Nayyar has published most often in Dermatol Surg. Dr. Nayyar's most frequent co-authors are Anne Lynn Su Chang, MD, Sonal Parikh, MD and Desiree Ratner, MD.

CMS Open Payments shows 89 general payments to Dr. Nayyar from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Galderma Laboratories, L.P. paid the most, $489.

Dr. Nayyar graduated from SUNY Downstate Health Sciences University in 2009.

Dr. Nayyar is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.